Czy ozdrowieńcy COVID-19 to przyszli pacjenci psychiatrów i psychologów? Szybki przegląd literatury naukowej

Makara-Studzińska, Marta; Załuski, Maciej; Lickiewicz, Jakub

doi:10.5603/psych.2021.0013

Cited by 3 publications

(4 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the cognitive difficulties observed in the patient at the end of hospitalization may be related both to the recent psychotic state and may also be the result of COVID-19. In the course of the above-mentioned disease, cognitive impairment has been reported, which may persist for 6 months to even 2 years as a result of the systemic inflammatory process and the affinity of the virus for the CNS [ 36 , 37 ]. Deterioration of cognitive functioning may concern its various aspects and manifest itself in weakening of fresh memory, attention function, and the so-called executive functions (including difficulties with inhibiting reactions, planning and solving problems, weakening cognitive flexibility) [ 37 , 38 ].…”

Section: Discussionmentioning

confidence: 99%

Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report

Tatar

Świerzy

Błachut

et al. 2022

IJERPH

View full text Add to dashboard Cite

The mental health impact of SARS-CoV-2 infection is currently the subject of intense research. Mental disorders in the course of coronavirus infection are non-specific. They most often have a sudden onset and short-term course and resolve spontaneously or after the administration of low doses of antipsychotic drugs. At the same time, attempts have been made to develop recommendations for COVID-19 therapy. Single reports suggest the effectiveness of amantadine in the treatment. The mechanism of action of the drug in this case is not known; it is expected that amantadine, by reducing the expression of the cathepsin L gene, may interfere with SARS-CoV-2 replication. In addition, this drug stimulates dopaminergic transmission, which may result in numerous side effects, often of a neuropsychological nature, the most common of which are visual hallucinations. Therefore, it is extremely difficult to unequivocally diagnose the cause of mental disorders among patients with SARS-CoV-2 infection who took amatatide for off-label treatment. A clear assessment of whether the psychological symptoms in this group of patients are the primary or secondary clinical manifestation of the infection or a complication of amantadine treatment is difficult. In this context, we attempted to describe a case of a patient with psychotic symptoms who was confirmed with SARS-CoV-2 infection and treated with amantadine.

show abstract

Section: Discussionmentioning

confidence: 99%

Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report

Tatar

Świerzy

Błachut

et al. 2022

IJERPH

View full text Add to dashboard Cite

show abstract

“…In the face of the SARS-CoV-2 pandemic, science and the world are faced with a very important question -how the pandemic, the COVID-19 infection and all the changes that occurred during the pandemic affected and will affect our mental health. The COVID-19 pandemic resembles the SARS-CoV and MERS-CoV pandemic in its course and psychopathological picture [93]. Therefore, based on these, researchers speculate on the likelihood of established physical and mental health disorders in COVID-19 survivors.…”

Section: Psychological and Social Aspects Of The Pandemic And Mental ...mentioning

confidence: 99%

“…Considering the available knowledge, patients in whom susceptibility to persistence of mental health disorders after COVID-19 treatment can be observed are those treated in the intensive care unit (especially intubated patients). In this group, symptoms of depression, PTSD, anxiety disorders, sleep disorders, symptoms of pain syndrome and chronic fatigue syndrome are more frequently diagnosed [93]. Considering the possibility of SARS-CoV-2 penetrating into the central nervous system, it may contribute to the induction of neurological and psychiatric symptoms, among other things: headaches, loss of consciousness, inappropriate sensation of stimuli, delirium, and cerebrovascular disease may be present [94].…”

Section: Psychological and Social Aspects Of The Pandemic And Mental ...mentioning

confidence: 99%

COVID-19 pandemic: disease impact on nervous system, cognitive functioning and mental health

Janeczek

2022

J Educ Health Sport

View full text Add to dashboard Cite

Introduction and purpose:COVID-19, as an unknown disease until 2019, has posed and continues to pose a great challenge to the world of science and the people facing it. The purpose of this article is to present the possible consequences of experiencing COVID-19 disease and the pandemic itself in light of mental health and the organism functioning in the cognitive area, taking into account the impact of COVID-19 on the nervous system.State of knowledge (brief description):Coronaviruses are enveloped, positive single-stranded large RNA viruses. COVID-19 is a disease caused by the SARS-CoV-2 virus – its first case was reported in 2019 in Wuhan, China. Human coronaviruses can exhibit neuroinvasive, neurotropic and neurovirulent, SARS-CoV-2 also. In addition to symptoms and complications in the respiratory system, symptoms and complications are also encountered in the nervous system area; cognitive functioning may also be impaired. The pandemic as a phenomenon in itself and the outbreak of COVID-19 can carry very serious consequences from the mental health field. Among these are the problem of social isolation and its consequences or the impact of the disease and pandemic on well-being. Unfortunately, the time that has elapsed since the first cases of the disease and the amount of research does not allow a clear determination of the complications and consequences of the pandemic, but certain trends and phenomena are regularly studied and described.Summary:Existing research and the state of the art strongly underscore that COVID-19 and its pandemic could impinge on the mental health of people around the world. Changes in the nervous system and cognitive functioning are also observed as a result of contracting COVID-19. Science currently has no clear answers as to how long certain complications will persist and exactly what their genesis is – further research is recommended to explain them as precisely as possible.

show abstract

“…Among the motives for suicide are: wanting to stop the pain, hopelessness, emptiness as well as seeking revenge. Revenge is the most common motive for suicide attempts among 14-18 year olds (Makara-Studzińska, 2013). The rate of suicidal behaviour in major depression is: for 'S' thoughts, 53.1%; 'S' tendencies, 17.5%; and for 'S' attempts, 23.7% (Dong et al, 2018(Dong et al, , 2019.…”

Section: Introductionmentioning

confidence: 99%

Risk factors and protective factors of suicidal behavior in people diagnosed with depression

Kucharska,

Gajewski

2023

FetR

View full text Add to dashboard Cite

According to the WHO, over 700,000 people commit suicide annually. Their main cause is clinical depression. It is predicted that by 2030 it will become the most diagnosed ailment among people. In the face of the pandemic of depression and suicidal behaviour, it is important to establish the so-called protective factors. Aim of the study: The main aim of the study was to analyse the relationship between protective factors (spirituality, religiosity) and suicidal risk factors (mental pain, depression, anxiety, fascination with death, coexistence of Borderline Personality Disorder BPD, self-harm) in people with a clinical depression. Methodology: The study was conducted from November 2022 to March 2023 using standardized tools and clinical scales to assess the above-mentioned variables. A total of 167 people were examined, while 96 people were qualified for the study, including 46 patients with depression and 50 people from the control group. Results: A significant number of subjects from the control group declaring mental health showed features of depressive disorders (27%), anxiety disorders (45%) and BPD (31.5%). Depressed participants compared to the control group, showed a lower level of spirituality and religiosity and a higher level of suicidal risk factors. Among people with depression, a positive effect of spirituality on lowering the fascination with death was shown, while religiosity correlated negatively with self-harm. In addition, psychological pain and fascination with death increased with the severity of anxiety, depression, self-harm, and BPD. In the examined group, the level of suicidal risk factors increased along with the religious crisis. Conclusions: The study partially confirmed the protective effect of spirituality and religiosity on people with depression in the context of suicidal risk. Religious crisis turned out to be a significant predictor of suicide risk

show abstract

Czy ozdrowieńcy COVID-19 to przyszli pacjenci psychiatrów i psychologów? Szybki przegląd literatury naukowej

Cited by 3 publications

References 33 publications

Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report

Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report

COVID-19 pandemic: disease impact on nervous system, cognitive functioning and mental health

Risk factors and protective factors of suicidal behavior in people diagnosed with depression

Contact Info

Product

Resources

About